Literature DB >> 28628364

Time to Stop Saying Geriatric Assessment Is Too Time Consuming.

Marije E Hamaker1, Tanya M Wildes1, Siri Rostoft1.   

Abstract

Mesh：

Year:  2017        PMID： 28628364     DOI： 10.1200/JCO.2017.72.8170

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  28 in total

1.  Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation.

Authors:  Maria Queralt Salas; Eshetu G Atenafu; Ora Bascom; Leeann Wilson; Wilson Lam; Arjun Datt Law; Ivan Pasic; Dennis Dong Hwan Kim; Fotios V Michelis; Zeyad Al-Shaibani; Armin Gerbitz; Auro Viswabandya; Jeffrey Howard Lipton; Jonas Mattsson; Shabbir M H Alibhai; Rajat Kumar
Journal:  Bone Marrow Transplant       Date:  2020-06-30       Impact factor: 5.483

2.  Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial.

Authors:  Elisabeth J M Driessen; Judith G M van Loon; Huub A Maas; Anne-Marie C Dingemans; Maryska L G Janssen-Heijnen
Journal:  Lung       Date:  2018-04-12       Impact factor: 2.584

Review 3.  Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology.

Authors:  Sukeshi Patel Arora; Gabor Liposits; Susan Caird; Richard F Dunne; Gordon Taylor Moffat; David Okonji; Maria Grazia Rodriquenz; Divyanshu Dua; Efrat Dotan
Journal:  J Geriatr Oncol       Date:  2019-11-06       Impact factor: 3.599

4.  Geriatric Assessment, Not ASA Physical Status, Is Associated With 6-Month Postoperative Survival in Patients With Cancer Aged ≥75 Years.

Authors:  Armin Shahrokni; Bella Marie Vishnevsky; Brian Jang; Saman Sarraf; Koshy Alexander; Soo Jung Kim; Robert Downey; Anoushka Afonso; Beatriz Korc-Grodzicki
Journal:  J Natl Compr Canc Netw       Date:  2019-06-01       Impact factor: 11.908

5.  Considerations for clinical trial design in older adults with cancer.

Authors:  Enrique Soto-Perez-De-Celis; Stuart M Lichtman
Journal:  Expert Opin Investig Drugs       Date:  2017-08-23       Impact factor: 6.206

6.  Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice.

Authors:  Heidi D Klepin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

7.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Authors:  Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria
Journal:  J Clin Oncol       Date:  2018-05-21       Impact factor: 44.544

Review 8.  Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma.

Authors:  Antonella Cammarota; Antonio D'Alessio; Tiziana Pressiani; Lorenza Rimassa; Nicola Personeni
Journal:  Drugs Aging       Date:  2021-06-21       Impact factor: 3.923

Review 9.  Older adults with cancer and their caregivers - current landscape and future directions for clinical care.

Authors:  Sindhuja Kadambi; Kah Poh Loh; Richard Dunne; Allison Magnuson; Ronald Maggiore; Jason Zittel; Marie Flannery; Julia Inglis; Nikesha Gilmore; Mostafa Mohamed; Erika Ramsdale; Supriya Mohile
Journal:  Nat Rev Clin Oncol       Date:  2020-09-02       Impact factor: 66.675

10.  Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).

Authors:  Heidi D Klepin; Ellen Ritchie; Brittny Major-Elechi; Jennifer Le-Rademacher; Drew Seisler; Libby Storrick; Ben L Sanford; Guido Marcucci; Weiqiang Zhao; Susan A Geyer; Karla V Ballman; Bayard L Powell; Maria R Baer; Wendy Stock; Harvey Jay Cohen; Richard M Stone; Richard A Larson; Geoffrey L Uy
Journal:  J Geriatr Oncol       Date:  2019-10-24       Impact factor: 3.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.